Chromotubation on the Remaining Fallopian Tube After a Laparoscopic Salpingectomy Due to Tubal Pr… (NCT06554964) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Chromotubation on the Remaining Fallopian Tube After a Laparoscopic Salpingectomy Due to Tubal Pregnancy
100 participantsStarted 2024-09-30
Plain-language summary
Ectopic pregnancy prevalence is approximately 1-2% of all pregnancies, majority of which located in the fallopian tube. Among the risk factors for ectopic pregnancy is tubal factor - meaning a mechanical problem within the fallopian tube resulting in the pregnancy remaining in the fallopian tube. The treatment o tubal pregnancy can be expectant, medical via metotrexate or surgicl via laparoscopic salpingectomy of the involved fallopian tube. The purpose of this study is to assess the feasibility of chromotubation during laparoscopic salpingectomy for the surgical management of tubal ectopic pregnancy hence assessing the function of the remaining fallopian tube and trying to predict future fertility for the patient.
Who can participate
Age range
18 Years – 50 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Exclusion criteria
. Patients with a history of unilateral salpingectomy
. Patients with suspected heterotopic pregnancy
. Patients with suspected allergic reaction to blue dye injection
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial tests whether a dye can pass through my remaining fallopian tube during surgery for an ectopic pregnancy — could this information about my remaining tube actually affect my future fertility treatment plan or next steps?
2Since this study is listed as 'not yet recruiting,' is it likely to be available at our hospital or a nearby center in time to be relevant to my situation, and should we wait or proceed with standard surgical management now?
3The trial is measuring how often the dye successfully passes through the remaining fallopian tube — if the dye doesn't pass, what would that mean for my chances of conceiving naturally, and would you change my care based on that result?
4Because this is a Phase NA study focused on a measurement during surgery rather than a new treatment, does participating add any extra risks or steps to the laparoscopic salpingectomy I'd already be having?
5Are there alternative ways to assess my remaining fallopian tube's health — like a hysterosalpingogram after recovery — that might give us similar information without being part of a study, so we can compare our options?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Precentage of successful chromotubation (passing of blue dye through the fallopian tube) during laparoscopic salpingectomy for the surgical management of tubal ectopic pregnancy.